Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI-9564 |
Trade Name | |
Synonyms | BI9564|BI 9564 |
Drug Descriptions |
BI-9564 is a selective BRD9 inhibitor that also has activity against BRD7 and CECR2, which has potential antitumor activity (PMID: 31000582, PMID: 26749027, PMID: 26914985). |
DrugClasses | |
CAS Registry Number | 1883429-22-8 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BAZ2-ICR + BI-9564 + JQ1 | BAZ2-ICR BI-9564 JQ1 | 0 | 0 |
BI-9564 | BI-9564 | 0 | 0 |